VALENCIA, Calif., Nov. 1 /PRNewswire-FirstCall/ -- MannKind Corporation , focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at two upcoming healthcare conferences: the CIBC World Markets 16th Annual Healthcare Conference to be held November 7-9, 2005 at The Waldorf-Astoria in New York and the Rodman & Renshaw Techvest 7th Annual Healthcare Conference also to be held on November 7-9, 2005 at The New York Palace Hotel.
Management is scheduled to speak at the CIBC conference on Tuesday, November 8, 2005 at 11:00 a.m. Eastern Time (8:00 a.m. PT) and at the Rodman & Renshaw conference on Wednesday, November 9, 2005 at 3:10 p.m. Eastern Time (12:10 p.m. PT). Management will provide an update on the Company.
Interested parties can access a link to the live web cast of each presentation in the Investor Relations section of the Company’s website at www.mannkindcorp.com. A replay of each presentation will be available for 14 days.
About MannKind Corporation
MannKind Corporation focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Its lead product, the Technosphere(R) Insulin System, is currently in phase 3 clinical trials in the U.S. and Europe to study its safety and efficacy in the treatment of diabetes. For more information on MannKind Corporation and its technology, visit www.mannkindcorp.com.
MannKind Corporation
CONTACT: Dick Anderson, Chief Financial Officer of MannKind Corporation,+1-661-775-5302, danderson@mannkindcorp.com; or Investors, Julie Huang ofFinancial Dynamics, +1-212-850-5628, Julie.Huang@fd.com, for MannKindCorporation
Web site: http://www.mannkindcorp.com/
